Characterization of a translocation within the von Recklinghausen neurofibromatosis region of chromosome 17.
The genetic defect causing von Recklinghausen neurofibromatosis (NF1) has been mapped to the proximal long arm of chromosome 17 by linkage analysis. Flanking markers have been identified, bracketing NF1 in 17q11.2 and laying the foundation for isolating the disease gene. Recently, a family in which a mother and her two children show both the symptoms of NF1 and the presence of a balanced translocation, t(1;17)(p34.3;q11.2), has been identified. We have examined the possibility that the translocation has occurred in or near the NF1 gene by constructing a somatic cell hybrid line containing the derivative chromosome 1 (1qter-p34.3::17q11-qter). On chromosome 1, the breakpoint occurred between SRC2 and D1S57, which are separated by 14 cM. The translocation breakpoint was localized on chromosome 17 between D17S33 and D17S57, markers that also flank NF1 within a region of 4 cM. These data are consistent with the possibility that the translocation event is the cause of NF1 in this pedigree. Consequently, the isolation of the translocation breakpoint, by approach from either the chromosome 1 or the chromosome 17 side, may facilitate the identification of the NF1 gene.
Menon
A G
AG
Neurogenetics Laboratory, Massachusetts General Hospital, Boston, Massachusetts 02114.
Ledbetter
D H
DH
Rich
D C
DC
Seizinger
B R
BR
Rouleau
G A
GA
Michels
V F
VF
Schmidt
M A
MA
Dewald
G
G
DallaTorre
C M
CM
Haines
J L
JL
D000818:Animals; D002886:Chromosomes, Human, Pair 17; D005260:Female; D005819:Genetic Markers; D006801:Humans; D006822:Hybrid Cells; D051379:Mice; D009456:Neurofibromatosis 1 / Q000235:genetics*; D015183:Restriction Mapping; D014178:Translocation, Genetic
D005819:Genetic Markers